BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20216201)

  • 1. Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature.
    Kazakov DV; Requena L; Kutzner H; Fernandez-Figueras MT; Kacerovska D; Mentzel T; Schwabbauer P; Michal M
    Am J Dermatopathol; 2010 Jun; 32(4):340-7. PubMed ID: 20216201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenoma papilliferum with a ductal carcinoma in situ component: case report and review of the literature.
    Vazmitel M; Spagnolo DV; Nemcova J; Michal M; Kazakov DV
    Am J Dermatopathol; 2008 Aug; 30(4):392-4. PubMed ID: 18645314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringocystadenocarcinoma papilliferum in situ with pagetoid spread: a case report.
    Woestenborghs H; Van Eyken P; Dans A
    Histopathology; 2006 Jun; 48(7):869-70. PubMed ID: 16722938
    [No Abstract]   [Full Text] [Related]  

  • 4. Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis.
    Arslan H; Diyarbakrl M; Batur S; Demirkesen C
    J Craniofac Surg; 2013 Jan; 24(1):e38-40. PubMed ID: 23348331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin.
    Langner C; Ott A
    APMIS; 2009 Feb; 117(2):148-50. PubMed ID: 19239438
    [No Abstract]   [Full Text] [Related]  

  • 6. Ductal carcinoma arising from a syringocystadenoma papilliferum in a nevus sebaceus of Jadassohn.
    Hügel H; Requena L
    Am J Dermatopathol; 2003 Dec; 25(6):490-3. PubMed ID: 14631190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syringocystadenocarcinoma papilliferum with transition to areas of squamous differentiation: a case report and review of the literature.
    Zhang YH; Wang WL; Rapini RP; Torres-Cabala C; Prieto VG; Curry JL
    Am J Dermatopathol; 2012 Jun; 34(4):428-33. PubMed ID: 22343110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
    Peterson J; Tefft K; Blackmon J; Rajpara A; Fraga G
    Dermatol Online J; 2013 Sep; 19(9):19620. PubMed ID: 24050294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum.
    Arai Y; Kusakabe H; Kiyokane K
    J Dermatol; 2003 Feb; 30(2):146-50. PubMed ID: 12692383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringocystadenoma papilliferum: a rare breast tumor in a young boy.
    Vaos G; Pierrakou P
    Pediatr Dev Pathol; 2006; 9(5):381-3. PubMed ID: 16953682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringocystadenocarcinoma papilliferum of the eyelid.
    Hoguet AS; Dolphin K; McCormick SA; Milman T
    Ophthalmic Plast Reconstr Surg; 2012; 28(1):e27-9. PubMed ID: 22266788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syringocystadenocarcinoma Papilliferum In Situ-Like Changes in Extramammary Paget Disease: A Report of 11 Cases.
    Konstantinova AM; Kacerovska D; Stewart CJ; Szepe P; Pitha J; Sulc M; Bencik V; Michal M; Shideler B; Kerl K; Kazakov DV
    Am J Dermatopathol; 2016 Dec; 38(12):882-886. PubMed ID: 26863065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syringocystadenocarcinoma papilliferum: a case report.
    Park SH; Shin YM; Shin DH; Choi JS; Kim KH
    J Korean Med Sci; 2007 Aug; 22(4):762-5. PubMed ID: 17728526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringocystadenocarcinoma papilliferum: case report and immunohistochemical comparison with its benign counterpart.
    Ishida-Yamamoto A; Sato K; Wada T; Takahashi H; Iizuka H
    J Am Acad Dermatol; 2001 Nov; 45(5):755-9. PubMed ID: 11606929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringocystadenocarcinoma papilliferum in situ of the penis.
    Plant MA; Sade S; Hong C; Ghazarian DM
    Eur J Dermatol; 2012; 22(3):405-6. PubMed ID: 22510243
    [No Abstract]   [Full Text] [Related]  

  • 16. A Histological Snapshot of Hypothetical Multistep Progression From Nevus Sebaceus to Invasive Syringocystadenocarcinoma Papilliferum.
    Parekh V; Guerrero CE; Knapp CF; Elmets CA; McKay KM
    Am J Dermatopathol; 2016 Jan; 38(1):56-62. PubMed ID: 26317389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syringocystadenocarcinoma papilliferum: Clinicopathologic analysis of 10 cases.
    Zhang Y; Kong YY; Cai X; Shen XX; Kong JC
    J Cutan Pathol; 2017 Jun; 44(6):538-543. PubMed ID: 28337777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringocystadenocarcinoma papilliferum.
    Sroa N; Sroa N; Zirwas M
    Dermatol Surg; 2010 Feb; 36(2):261-3. PubMed ID: 20002633
    [No Abstract]   [Full Text] [Related]  

  • 19. Syringocystadenoma papilliferum: report of 8 cases.
    Rammeh-Rommani S; Fezaa B; Chelbi E; Kammoun MR; Ben Jilani SB; Zermani R
    Pathologica; 2006 Jun; 98(3):178-80. PubMed ID: 17036946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringocystadenocarcinoma papilliferum with intraepidermal pagetoid spread on an unusual location.
    Shan SJ; Chen S; Heller P; Guo Y
    Am J Dermatopathol; 2014 Dec; 36(12):1007-10. PubMed ID: 24423933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.